Abilify

ABILIFY is indicated for the treatment of Schizophrenia in adults and adolescents (13 to 17 years of age).

ABILIFY has been shown to help improve a range of symptoms associated with Schizophrenia, which may include:

* hearing voices
* thinking unclearly
* having uncomfortable or disturbing thoughts
* feeling confused
* lacking interest in the things you previously enjoyed

Studies have shown that you may feel improvement of symptoms a few weeks after starting therapy.

ABILIFY has also been shown to help maintain stability in patients who have been able to remain stable while on other antipsychotic medications for periods of 3 months or longer and observed for relapse during a period of up to 26 weeks.

People may respond differently to different medications, so it is important for you to give your body time to adjust to ABILIFY and continue to talk with your doctor about how you are feeling.